News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Meda AB (SE:MEDAa) Expands Axorid Collaboration With Ethypharm



12/30/2009 8:55:28 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) expands the collaboration with the French development company Ethypharm for the patented product Axorid. New territories, such as East Europe with Russia and Turkey, are now included in the collaboration. Previously, Meda held commercialization rights in Central and West Europe.

Read at BioSpace.com


comments powered by Disqus
Ethypharm
Meda AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES